The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Corynebacterium


Psychiatry related information on Corynebacterium

  • A randomized prospective therapy trial in patients with stage III optimal epithelial carcinoma of the ovary was accomplished by the Gynecologic Oncology Group. Therapy with melphalan or melphalan plus immuno-adjuvant, Corynebacterium parvum (C. parvum), was utilized as adjuvant treatment following surgical therapy [6].

High impact information on Corynebacterium


Chemical compound and disease context of Corynebacterium


Biological context of Corynebacterium


Anatomical context of Corynebacterium


Gene context of Corynebacterium


Analytical, diagnostic and therapeutic context of Corynebacterium


  1. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants. Anderson, E.L., Decker, M.D., Englund, J.A., Edwards, K.M., Anderson, P., McInnes, P., Belshe, R.B. JAMA (1995) [Pubmed]
  2. Intralesional immunotherapy of brain tumors with combined Corynebacterium parvum and recombinant interleukin-2 in mice. Conley, F.K., Adler, J.R., Duncan, J.A., Kennedy, J.D., Sutton, R.C. J. Natl. Cancer Inst. (1990) [Pubmed]
  3. Iron chelates bind nitric oxide and decrease mortality in an experimental model of septic shock. Kazmierski, W.M., Wolberg, G., Wilson, J.G., Smith, S.R., Williams, D.S., Thorp, H.H., Molina, L. Proc. Natl. Acad. Sci. U.S.A. (1996) [Pubmed]
  4. Expression of metastatic potential of allogenic and xenogeneic neoplasms in young nude mice. Hanna, N., Fidler, I.J. Cancer Res. (1981) [Pubmed]
  5. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma. Purnell, D.M., Bartlett, G.L., Kreider, J.W., Biro, T.G. Cancer Res. (1977) [Pubmed]
  6. Therapy of stage III (optimal) epithelial carcinoma of the ovary with melphalan or melphalan plus Corynebacterium parvum (a Gynecologic Oncology Group Study). Gall, S., Bundy, B., Beecham, J., Whitney, C., Homesley, H., Lifshitz, S., Adcock, L.L. Gynecol. Oncol. (1986) [Pubmed]
  7. Factor B, the complement alternative pathway serine proteinase, is a major constitutive protein synthesized and secreted by resident and elicited mouse macrophages. Sundsmo, J.S., Chin, J.R., Papin, R.A., Fair, D.S., Werb, Z. J. Exp. Med. (1985) [Pubmed]
  8. Hybrid resistance to EL-4 lymphoma cells. I. Characterization of natural killer cells that lyse EL-4 cells and their distinction from marrow-dependent natural killer cells. Kumar, V., Luevano, E., Bennett, M. J. Exp. Med. (1979) [Pubmed]
  9. Macrophage activation: increased ingestion of IgG-coated erythrocytes after administration of interferon inducers to mice. Hamburg, S.I., Manejias, R.E., Rabinovitch, M. J. Exp. Med. (1978) [Pubmed]
  10. Alpha-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. Chiao, H., Foster, S., Thomas, R., Lipton, J., Star, R.A. J. Clin. Invest. (1996) [Pubmed]
  11. Murine tumor necrosis-inducing factor: purification and effects on myelomonocytic leukemia cells. Green, S., Dobrjansky, A., Chiasson, M.A. J. Natl. Cancer Inst. (1982) [Pubmed]
  12. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. IX. Macrophage content of tumors in mice. Gebhardt, M.C., Fisher, B. J. Natl. Cancer Inst. (1979) [Pubmed]
  13. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. II. Effect of cortisone acetate. Fisher, B., Rubin, H., Saffer, E., Wolmark, N. J. Natl. Cancer Inst. (1976) [Pubmed]
  14. Effect of adriamycin and Corynebacterium parvum in tumor-bearing mice: modulation of response to sheep red blood cells. Dimitrov, N.V., Denny, T.N., Weisman, M.F., Cameron, D.G. J. Natl. Cancer Inst. (1979) [Pubmed]
  15. Dose, route, and time dependence of serum lysozyme and antitumor activity following administration of glucan, Corynebacterium parvum, pyran, or lipopolysaccharide to mice. Gorecka-Tisera, A., Proctor, J.W., Yamamura, Y., Harnaha, J., Meinert, K. J. Natl. Cancer Inst. (1981) [Pubmed]
  16. Role of macrophage in in vitro augmentation of rat, mouse, and human natural killer activities. Reynolds, C.W., Brunda, M.J., Holden, H.T., Herberman, R.B. J. Natl. Cancer Inst. (1981) [Pubmed]
  17. Molecular cloning and DNA sequence analysis of a diphtheria tox iron-dependent regulatory element (dtxR) from Corynebacterium diphtheriae. Boyd, J., Oza, M.N., Murphy, J.R. Proc. Natl. Acad. Sci. U.S.A. (1990) [Pubmed]
  18. Sensitivity to chemotherapeutic and immunomodulating agents of two mouse lymphomas and of a macrophage tumor. Tarnowski, G.S., Ralph, P., Stock, C.C. Cancer Res. (1979) [Pubmed]
  19. The Gene ncgl2918 Encodes a Novel Maleylpyruvate Isomerase That Needs Mycothiol as Cofactor and Links Mycothiol Biosynthesis and Gentisate Assimilation in Corynebacterium glutamicum. Feng, J., Che, Y., Milse, J., Yin, Y.J., Liu, L., Rückert, C., Shen, X.H., Qi, S.W., Kalinowski, J., Liu, S.J. J. Biol. Chem. (2006) [Pubmed]
  20. Solution 1H NMR investigation of the active site molecular and electronic structures of substrate-bound, cyanide-inhibited HmuO, a bacterial heme oxygenase from Corynebacterium diphtheriae. Li, Y., Syvitski, R.T., Chu, G.C., Ikeda-Saito, M., Mar, G.N. J. Biol. Chem. (2003) [Pubmed]
  21. Nucleotide sequence of the erythromycin resistance gene from the Corynebacterium plasmid pNG2. Hodgson, A.L., Krywult, J., Radford, A.J. Nucleic Acids Res. (1990) [Pubmed]
  22. In vivo cortisone sensitivity of nonspecific antitumor activity of Corynebacterium parvum-activated mouse peritoneal macrophages. Scott, M.T. J. Natl. Cancer Inst. (1975) [Pubmed]
  23. Correlation of antitumor chemoimmunotherapy with bone marrow macrophage precursor cell stimulation and macrophage cytotoxicity. Fisher, B., Wolmark, N. Cancer Res. (1976) [Pubmed]
  24. Eicosanoid production by peritoneal and splenic macrophages in mice depleted of bone marrow by 89Sr. Shibata, Y., Bautista, A.P., Pennington, S.N., Humes, J.L., Volkman, A. Am. J. Pathol. (1987) [Pubmed]
  25. The effect of hemopoietic microenvironment on splenic suppressor macrophages in congenitally anemic mice of genotype Sl/Sld. Shibata, Y., Volkman, A. J. Immunol. (1985) [Pubmed]
  26. Evidence for a partial redundancy of the fibronectin-binding proteins for the transfer of mycoloyl residues onto the cell wall arabinogalactan termini of Mycobacterium tuberculosis. Puech, V., Guilhot, C., Perez, E., Tropis, M., Armitige, L.Y., Gicquel, B., Daffé, M. Mol. Microbiol. (2002) [Pubmed]
  27. Inhibition of interferon gamma induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Hodge-Dufour, J., Marino, M.W., Horton, M.R., Jungbluth, A., Burdick, M.D., Strieter, R.M., Noble, P.W., Hunter, C.A., Puré, E. Proc. Natl. Acad. Sci. U.S.A. (1998) [Pubmed]
  28. Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice. Ambs, S., Ogunfusika, M.O., Merriam, W.G., Bennett, W.P., Billiar, T.R., Harris, C.C. Proc. Natl. Acad. Sci. U.S.A. (1998) [Pubmed]
  29. Tumor necrosis factor-alpha regulates in vivo nitric oxide synthesis and induces liver injury during endotoxemia. Harbrecht, B.G., Di Silvio, M., Demetris, A.J., Simmons, R.L., Billiar, T.R. Hepatology (1994) [Pubmed]
  30. B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum. Chen, L., McGowan, P., Ashe, S., Johnston, J.V., Hellström, I., Hellström, K.E. Cancer Res. (1994) [Pubmed]
  31. Roles of distal Asp in heme oxygenase from Corynebacterium diphtheriae, HmuO: A water-driven oxygen activation mechanism. Matsui, T., Furukawa, M., Unno, M., Tomita, T., Ikeda-Saito, M. J. Biol. Chem. (2005) [Pubmed]
  32. Effect of immunotherapy with Corynebacterium parvum and methanol extraction residue of BCG administered intravenously on host defense function in cancer patients. Hersh, E.M., Murphy, S.G., Quesada, J.R., Gutterman, J.U., Gschwind, C.R., Morgan, J. J. Natl. Cancer Inst. (1981) [Pubmed]
  33. Systemic therapy for metastatic breast cancer. Haskell, C.M., Sparks, F.C., Graze, P.R., Korenman, S.G. Ann. Intern. Med. (1977) [Pubmed]
  34. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum. Miyata, H., Himeno, K., Nomoto, K. Cancer Res. (1983) [Pubmed]
  35. Differential expression of membrane sialoglycoproteins in exudate and resident mouse peritoneal macrophages. Rabinowitz, S., Gordon, S. J. Cell. Sci. (1989) [Pubmed]
  36. Modulation of suppressor mechanisms in allergic contact dermatitis: 2. Inhibition of suppressor T-lymphocytes by Corynebacterium parvum. Knop, J., Riechmann, R., Macher, E. J. Invest. Dermatol. (1981) [Pubmed]
WikiGenes - Universities